RPG Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Dec' 23	Sep' 23	Jun' 23	Mar' 23	Dec' 22

Sales

153.70

153.58

147.78

118.49

130.60

Operating profit

37.90

37.29

32.24

15.91

29.21

Interest

0.14

0.10

0.07

0.05

0.07

Gross profit

39.68

39.02

33.98

17.70

29.65

EPS (Rs)

16.00

15.64

13.36

6.26

11.56

Other income

1.92

1.83

1.81

1.84

0.51

Stock adjustment

6.83

-5.67

3.05

-3.19

-3.18

Raw material

24.85

37.30

30.47

22.42

20.26

Power and fuel

-

-

-

-

-

Employee expenses

33.69

33.59

32.79

33.77

28.29

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

50.43

51.07

49.23

49.58

56.02

Provisions made

-

-

-

-

-

Depreciation

4.14

4.23

4.21

3.89

3.91

Taxation

9.08

8.93

7.67

3.46

6.63

Net profit / loss

26.46

25.86

22.10

10.35

19.11

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.23

13.23

13.23

13.23

13.23

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

24.66

24.28

21.82

13.43

22.37

GPM (%)

25.50

25.11

22.72

14.71

22.61

NPM (%)

17.00

16.64

14.77

8.60

14.58